Evidence map›Paper›PMID 38893258›Full record

ArticleCancers2024

Functional Investigation of

Sofia Catalina Heredia-Guerrero, Marietheres Evers, Sarah Keppler, Marlene Schwarzfischer, Viktoria Fuhr, Hilka Rauert-Wunderlich, Anne Krügl, Theodora Nedeva, Tina Grieb, Julia Pickert and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Sofia Catalina Heredia-GuerreroInstitute of Pathology, University of Würzburg, 97080 Würzburg, Germany.ORCID 0009-0006-2907-8399
Marietheres EversInstitute of Pathology, University of Würzburg, 97080 Würzburg, Germany.ORCID 0009-0004-1012-3909
Sarah KepplerInstitute of Pathology, University of Würzburg, 97080 Würzburg, Germany.
Marlene SchwarzfischerInstitute of Pathology, University of Würzburg, 97080 Würzburg, Germany.
Viktoria FuhrInstitute of Pathology, University of Würzburg, 97080 Würzburg, Germany.
Hilka Rauert-WunderlichInstitute of Pathology, University of Würzburg, 97080 Würzburg, Germany.ORCID 0000-0002-5535-2412
Anne KrüglInstitute of Pathology, University of Würzburg, 97080 Würzburg, Germany.
Theodora NedevaInstitute of Pathology, University of Würzburg, 97080 Würzburg, Germany.
Tina GriebInstitute of Pathology, University of Würzburg, 97080 Würzburg, Germany.
Julia PickertInstitute of Pathology, University of Würzburg, 97080 Würzburg, Germany.ORCID 0009-0001-1985-9259
Hanna KochInstitute of Pathology, University of Würzburg, 97080 Würzburg, Germany.
Torsten SteinbrunnDepartment of Internal Medicine II, University Hospital Würzburg, 97080 Würzburg, Germany.ORCID 0000-0002-8793-9998
Otto-Jonas BayrhofComprehensive Cancer Center Mainfranken, University Hospital Würzburg, 97080 Würzburg, Germany.
Ralf Christian BargouComprehensive Cancer Center Mainfranken, University Hospital Würzburg, 97080 Würzburg, Germany.
Andreas RosenwaldInstitute of Pathology, University of Würzburg, 97080 Würzburg, Germany.
Thorsten StühmerComprehensive Cancer Center Mainfranken, University Hospital Würzburg, 97080 Würzburg, Germany.
Ellen LeichInstitute of Pathology, University of Würzburg, 97080 Würzburg, Germany.

Funding

Deutsche Forschungsgemeinschaft 442740310German Cancer Aid 70112693
6 · The paper itself

Abstract

High expression of the receptor tyrosine kinase (RTK) insulin-like growth factor-1 receptor (

Indexed as

carfilzomibIGF1R mutationslinsitinibmultiple myelomareceptor tyrosine kinase signaling

Identifiers

PMID38893258
PMCPMC11171363

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.